SWOG clinical trial number
SWOG-9157

Trial of All Trans-Retinoic Acid in Hepatoma, Phase II.

Closed
Phase
Accrual
86%
Published
Abbreviated Title
Trial of All Trans-Retinoic Acid in Hepatoma, Phase II.
Activated
06/01/1993
Closed
08/01/1994

Research committees

Gastrointestinal Cancer

Publication Information Expand/Collapse

1998

Phase II trial of oral B-all trans-retinoic acid in hepatocellular carcinoma (SWOG-9157).

FL Meyskens Jr;J Jacobson;B Nguyen;GR Weiss;DR Gandara;JS Macdonald Investigational New Drugs 16(2):171-173

1996

Phase II trial of B-trans-retinoic acid (TRA) in primary hepatomas (SWOG-9157).

FL Meyskens Jr;B Nguyen;J Jacobson;J Macdonald American Society of Clinical Oncology 15:229(#559)